Research Output 1973 2017

Filter
Comment/debate
2010

Quantitation of individual risk for osteoporotic fracture.

Wood, W. A. & Muss, H. Jul 2010 In : Oncology (Williston Park, N.Y.). 24, 8, p. 753-755 3 p.

Research output: Contribution to journalComment/debate

Bone Density Conservation Agents
Aromatase Inhibitors
Osteoporotic Fractures
Bone Remodeling
Bone Fractures
2006
1 Citations
aprepitant
Nausea
Vomiting
Drug Therapy
Neoplasms

The future

Muss, H. B. 2006 In : Oncology. 20, 2

Research output: Contribution to journalComment/debate

2005

Erratum: Recommendations for a global core curriculum in medical oncology (Annals of Oncology (2004) vol. 15 (1603-1612))

Hansen, H. H., Bajorin, D. F., Muss, H. B., Purkalne, G., Schrijvers, D. & Stahel, R. Jan 2005 In : Annals of Oncology. 16, 1, p. 177 1 p.

Research output: Contribution to journalComment/debate

Medical Oncology
Curriculum
2001
30 Citations

Older age--not a barrier to cancer treatment.

Muss, H. B. Oct 11 2001 In : New England Journal of Medicine. 345, 15, p. 1127-1128 2 p.

Research output: Contribution to journalComment/debate

Antineoplastic Combined Chemotherapy Protocols
Age Factors
Adjuvant Chemotherapy
Survival Analysis
Fluorouracil
1995

Role of chemotherapy dose intensification in the treatment of advanced ovarian cancer. Commentaries

Homesley, H. D., Muss, H. B. & Ozols, R. F. 1995 In : ONCOLOGY. 9, 10

Research output: Contribution to journalComment/debate

Ovarian Neoplasms
Drug Therapy
Therapeutics
1989
3 Citations

Megestrol acetate in breast cancer - A panel discussion

McGuire, W. L., Johnson, P. A., Muss, H. B. & Osborne, C. K. 1989 In : Breast Cancer Research and Treatment. 14, 1, p. 33-38 6 p.

Research output: Contribution to journalComment/debate

Drug Dose Response Relationship
Megestrol
Megestrol Acetate
Combined Modality Therapy
Progesterone Receptors